Clinical Trial Update: Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial assessing multiple-dose ranges of oral semaglutide in type 2 diabetes; results completed with efficacy data posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• oral semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2019-11-05